698 related articles for article (PubMed ID: 22932115)
21. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
22. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
24. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
Takamura T; Yamamoto I; Nakada Y; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.
Schwaiger E; Regele H; Wahrmann M; Werzowa J; Haidbauer B; Schmidt A; Böhmig GA
Clin Transpl; 2010; ():391-6. PubMed ID: 21696056
[TBL] [Abstract][Full Text] [Related]
26. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.
Loupy A; Suberbielle-Boissel C; Hill GS; Lefaucheur C; Anglicheau D; Zuber J; Martinez F; Thervet E; Méjean A; Charron D; Duong van Huyen JP; Bruneval P; Legendre C; Nochy D
Am J Transplant; 2009 Nov; 9(11):2561-70. PubMed ID: 19775320
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Pathological Features of Plasma Cell-Rich Acute Rejection After Kidney Transplantation.
Hasegawa J; Honda K; Omoto K; Wakai S; Shirakawa H; Okumi M; Ishida H; Fuchinoue S; Hattori M; Tanabe K
Transplantation; 2018 May; 102(5):853-859. PubMed ID: 29319615
[TBL] [Abstract][Full Text] [Related]
28. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
29. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
30. C4d-negative antibody-mediated rejection: A pathologist's perspective and clinical outcome.
Nigam LK; Vanikar AV; Kanodia KV; Patel RD; Suthar KS; Patel HV
Saudi J Kidney Dis Transpl; 2018; 29(1):39-49. PubMed ID: 29456206
[TBL] [Abstract][Full Text] [Related]
31. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
[TBL] [Abstract][Full Text] [Related]
32. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
[TBL] [Abstract][Full Text] [Related]
33. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.
Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260
[TBL] [Abstract][Full Text] [Related]
34. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
Orandi BJ; Alachkar N; Kraus ES; Naqvi F; Lonze BE; Lees L; Van Arendonk KJ; Wickliffe C; Bagnasco SM; Zachary AA; Segev DL; Montgomery RA
Am J Transplant; 2016 Jan; 16(1):213-20. PubMed ID: 26317487
[TBL] [Abstract][Full Text] [Related]
35. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.
Rovira J; Ramírez-Bajo MJ; Banon-Maneus E; Lazo-Rodríguez M; Moya-Rull D; Hierro-Garcia N; Tubita V; Piñeiro GJ; Revuelta I; Ventura-Aguiar P; Cucchiari D; Oppenheimer F; Brunet M; Campistol JM; Diekmann F
Transplantation; 2018 Jul; 102(7):1075-1084. PubMed ID: 29620612
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
[TBL] [Abstract][Full Text] [Related]
37. The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection.
Akagun T; Yazici H; Caliskan Y; Ozluk Y; Sahin S; Turkmen A; Kılıcaslan I; Sever MS
Ren Fail; 2017 Nov; 39(1):19-25. PubMed ID: 27776435
[TBL] [Abstract][Full Text] [Related]
38. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.
Sicard A; Ducreux S; Rabeyrin M; Couzi L; McGregor B; Badet L; Scoazec JY; Bachelet T; Lepreux S; Visentin J; Merville P; Fremeaux-Bacchi V; Morelon E; Taupin JL; Dubois V; Thaunat O
J Am Soc Nephrol; 2015 Feb; 26(2):457-67. PubMed ID: 25125383
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Early Clinical and Subclinical T Cell-mediated Rejection After Kidney Transplantation.
Hoffman W; Mehta R; Jorgensen DR; Sood P; Randhawa P; Wu CM; Puttarajappa C; Shah NA; Tevar AD; Hariharan S
Transplantation; 2019 Jul; 103(7):1457-1467. PubMed ID: 30747837
[TBL] [Abstract][Full Text] [Related]
40. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.
Wu K; Budde K; Lu H; Schmidt D; Liefeldt L; Glander P; Neumayer HH; Rudolph B
Transplantation; 2014 Jun; 97(11):1146-54. PubMed ID: 24892962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
